Oleksi Petrenko

Also affiliated with Cancer Research Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Intratumor heterogeneity in KRAS signaling shapes treatment resistance”.

Intratumor heterogeneity in KRAS signaling shapes treatment resistance

iScience(2024)10.1016/j.isci.2024.111662

N/A

0.266DataRank · unranked

4 citations

Varvara Kirillov, Stephen D’Amico, Nancy C. Reich, Oleksi Petrenko

STAT3 is a genetic modifier of TGF-beta induced EMT in KRAS mutant pancreatic cancer

eLife(2024)10.7554/elife.92559

N/A

0.253DataRank · unranked

4 citations

Varvara Kirillov, Oleksi Petrenko, Nancy C. Reich, Stephen D’Amico

Oncogenic dependency plays a dominant role in the immune response to cancer

Proceedings of the National Academy of Sciences(2023)10.1073/pnas.2308635120

N/A

0DataRank · unranked

7 citations

Stephen D’Amico, Varvara Kirillov, Oleksi Petrenko, Nancy C. Reich, Jinyu Li

STAT3 is a genetic modifier of TGF-beta induced EMT in KRAS mutant pancreatic cancer

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.09.01.555946

N/A

0DataRank · unranked

2 citations

Varvara Kirillov, Oleksi Petrenko, Nancy C. Reich, Stephen D’Amico

Data from Mitochondrially Targeted p53 Has Tumor Suppressor Activities In vivo

(2023)10.1158/0008-5472.c.6495930

N/A

0DataRank · unranked

0 citations

Oleksi Petrenko, Patricio Mena, Ute M. Moll, Flaminia Talos

Data from Mitochondrially Targeted p53 Has Tumor Suppressor Activities In vivo

(2023)10.1158/0008-5472.c.6495930.v1

N/A

0DataRank · unranked

0 citations

Oleksi Petrenko, Patricio Mena, Ute M. Moll, Flaminia Talos

KRAS drives immune evasion in a genetic model of pancreatic cancer

Nature Communications(2021)10.1038/s41467-021-21736-w

N/A

0DataRank · unranked

188 citations

Stephen D’Amico, Manisha Rao, Jinyu Li, Michael J. Hayman, Scott Powers +3 more

STAT3 is a genetic modifier of TGF-beta induced EMT in KRAS mutant pancreatic cancer

eLife(2024)10.7554/elife.92559.1

N/A

0DataRank · unranked

0 citations

Varvara Kirillov, Oleksi Petrenko, Nancy C. Reich, Stephen D’Amico

IL-6 promotes MYC-induced B cell lymphomagenesis independent of STAT3

PLoS ONE(2021)10.1371/journal.pone.0247394

N/A

0DataRank · unranked

10 citations

Jinyu Li, Velasco Cimica, Patricio Mena-Taboada, Ha Youn Shin, Stephen D’Amico +2 more